Skip to main content

Masks are still required at all locations. Please read important information about visiting hours and COVID-19 vaccination requirements or testing for some visitors. Read More

Memorial Sloan Kettering Cancer Center
  • Sloan Kettering Institute
  • Research
      • Changing how the world understands and treats cancer

        Our scientists pursue every aspect of cancer research—from exploring the biology of genes and cells, to developing immune-based treatments, uncovering the causes of metastasis, and more.

      • Programs & Centers
      • Sloan Kettering Institute
        Pursuing basic and translational research across 9 programs and 100+ labs
      • Memorial Hospital research
        Focusing on clinical cancer research and population health
      • Human Oncology & Pathogenesis Program (HOPP)
        Bridging the lab and the clinic through translational research
      • Collaborative research centers
        Fostering interdisciplinary collaborations between laboratory scientists and clinicians
      • Extramural collaborations
        Partnering with other academic and research institutions
      • Research at MSK
      • Our research impact
      • Research topics
      • Core facilities & resources
        Offering state-of-the-art resources for our researchers
      • Find a researcher or lab
      • Education & training programs
  • Education & Training
      • Training the next generation of clinicians and scientists

        Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research.

      • For Healthcare
      • Graduate medical education (GME)
      • Medical student opportunities
      • Continuing medical education (CME)
      • Continuing nursing education (CNE)
      • Academic departments & divisions
      • Explore all programs
      • For Research
      • Postdoctoral training
      • Gerstner Sloan Kettering Graduate School of Biomedical Sciences
        Offering a curriculum with a focus on cancer
      • PhD & MD/PhD programs
      • MSK Bridge program
        Connecting college seniors to future careers in biomedicine
      • High school & undergraduate summer programs
  • Careers
  • MSK Direct
      • In the U.S.
      • English
      • Español
      • Pу́сский
      • Outside of the U.S.
      • العَرَبِيَّة
      • Deutsch
      • English
      • Español
      • 한국어
      • עִבְרִית
      • Italiano
      • Português
      • Pу́сский
      • Türkçe
      • 中文
  • Make an Appointment
      • We’re here for you.

        Make an appointment

        New patient
        Current patient

        Speak to a care advisor

        Adults: 833-920-3234

        Monday to Friday, 8 a.m. to 6 p.m. (Eastern time)

        Children & Teens: 833-MSK-KIDS

        Monday to Friday, 9 a.m. to 5 p.m. (Eastern time)

      • Becoming A Patient
      • How to get started
      • Insurance & financial assistance
      • Preparing for your first appointment
      • Meet our doctors
      • Explore our locations
  • Refer a Patient
      • Partner with us to treat your patient’s cancer.

        Refer a patient

        Call Physician Access Team

        833-340-1151

        Monday to Friday, 8 a.m. to 6 p.m. (Eastern time)

      • Clinical Resources
      • Our doctors
      • Physician relations
      • Clinical updates & insights
      • Prediction tools
      • Clinical trials
      • Continuing medical education (CME)
  • Learn About Cancer & Treatment
      • We treat every type of cancer, including the most important one: yours.

        With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need, when you need it.

      • Adults
      • Cancers & conditions
      • Risk assessment & screening
      • Diagnosis & treatment
      • Clinical trials
      • Children & Teens
      • Cancers & conditions
      • Diagnosis & treatment
      • Clinical trials
      • Support, Services & Programs
      • For adults
      • For children & teens
      • For caregivers
      • Adolescents & young adult (AYA) program
      • Patient & caregiver education library
      • Cancer News & Discoveries
      • Read the latest
      • Sign up for our newsletter
  • About Us
      • We’re always leading the fight against cancer.

        Memorial Sloan Kettering was founded in 1884, and today is a world leader in patient care, research, and educational programs.

      • About Us
      • Leadership
      • History
      • Equality, diversity & inclusion
      • Annual report
      • Give to MSK
      • For the Media
      • Media inquiries
      • News releases
      • News & information
      • Have Questions?
      • Contact us
      • Plan Your Visit
      • Explore our locations
      • Directions
      • Visitor policy
  • Patient Portal: MyMSK
  • Donate Now
    • Sloan Kettering Institute
    • Research
        • Programs & Centers
        • Sloan Kettering Institute
          Pursuing basic and translational research across 9 programs and 100+ labs
        • Memorial Hospital research
          Focusing on clinical cancer research and population health
        • Human Oncology & Pathogenesis Program (HOPP)
          Bridging the lab and the clinic through translational research
        • Collaborative research centers
          Fostering interdisciplinary collaborations between laboratory scientists and clinicians
        • Extramural collaborations
          Partnering with other academic and research institutions
        • Research at MSK
        • Our research impact
        • Research topics
        • Core facilities & resources
          Offering state-of-the-art resources for our researchers
        • Find a researcher or lab
        • Education & training programs
    • Education & Training
        • For Healthcare
        • Graduate medical education (GME)
        • Medical student opportunities
        • Continuing medical education (CME)
        • Continuing nursing education (CNE)
        • Academic departments & divisions
        • Explore all programs
        • For Research
        • Postdoctoral training
        • Gerstner Sloan Kettering Graduate School of Biomedical Sciences
          Offering a curriculum with a focus on cancer
        • PhD & MD/PhD programs
        • MSK Bridge program
          Connecting college seniors to future careers in biomedicine
        • High school & undergraduate summer programs
    • Careers
    • MSK Direct
        • In the U.S.
        • English
        • Español
        • Pу́сский
        • Outside of the U.S.
        • العَرَبِيَّة
        • Deutsch
        • English
        • Español
        • 한국어
        • עִבְרִית
        • Italiano
        • Português
        • Pу́сский
        • Türkçe
        • 中文
  • For Research Scientists

Ana Sanchez

For Research Scientists
More About For Research Scientists
Research Programs
  • Overview
  • Sloan Kettering Institute
  • Memorial Hospital Research
  • Collaborative Research Centers
  • Extramural Collaborations
Research Areas
  • Overview
  • Research Topics
  • Clinical Research & Trials
  • Research Labs
  • Research Faculty & Staff
Education & Training
  • Overview
  • MSK Bridge Program
  • The NCI Awardee Skills Development Consortium (NASDC)
  • Gerstner Sloan Kettering Graduate School of Biomedical Sciences
  • Postdoctoral Research Training
  • PhD & MD/PhD Education
  • High School & College Programs
Our Research Advantage
  • Overview
  • About Our Research
  • Researcher Interviews
  • Core Facilities & Resources
  • Research Support
  • Awards & Honors
  • Inaccessible
  • The Josie Robertson Investigators

Ana Sanchez

Share
Share
GSK Student

Email

[email protected]

Mentor

Stewart Shuman, MD, PhD

Start Year

2019

Education

BS, John Jay College of Criminal Justice

Fellowships

  • National Science Foundation Graduate Research Fellowship Award (2021-)

Publications

Schwer B, Garg A, Sanchez AM, Bernstein MA, Benjamin B, Shuman S. (2022) Cleavage-Polyadenylation Factor Cft1 and SPX Domain Proteins Are Agents of Inositol Pyrophosphate Toxicosis in Fission Yeast. mBio 13.

Sanchez AM, Garg A, Shuman S, Schwer B (2020) Genetic interactions and transcriptomics implicate fission yeast CTD prolyl isomerase Pin1 as an agent of RNA 3’ processing and transcription termination that functions via its effects on CTD phosphatase Ssu72. Nucleic Acids Res.48 4811-4826

Schwer B, Sanchez AM, Shuman S. (2020) Inactivation of fission yeast Erh1 de-represses pho1 expression: evidence that Erh1 is a negative regulator of prt lncRNA termination. RNA 10. 1334-1344

Sanchez AM, Jacewicz A, Shuman S. (2022) Fission yeast Duf89 and Duf8901 are cobalt/nickel-dependent phosphatase-pyrophosphatases that act via a covalent aspartyl-phosphate intermediate. J Biol Chem.

Connect
Connect
  • Contact us
  • Locations
  • Appointments
    800-525-2225
About MSK
About MSK
  • About us
  • Careers
  • Giving
Cancer Care
Cancer Care
  • Adult cancer types
  • Child & teen cancer types
  • Integrative medicine
  • Nutrition & cancer
  • Find a doctor
Research & Education
Research & Education
  • Sloan Kettering Institute
  • Gerstner Sloan Kettering Graduate School
  • Graduate medical education
  • MSK Library
Memorial Sloan Kettering Cancer Center
  • Manage communication preferences
  • Legal disclaimer
  • Privacy policy
  • Public notices
© 2022 Memorial Sloan Kettering Cancer Center
Log in web-44142.prod.hosting.acquia.com